Luxford, J. C., Casey, C. E., Roberts, P. A., & Irving, C. A. (2024). Iron deficiency and anemia in pediatric dilated cardiomyopathy are associated with clinical, biochemical, and hematological markers of severe disease and adverse outcomes. The Journal of heart and lung transplantation, 43(3), 379. https://doi.org/10.1016/j.healun.2023.11.014
Citácia podle Chicago (17th ed.)Luxford, Jack C., Charlene E. Casey, Philip A. Roberts, a Claire A. Irving. "Iron Deficiency and Anemia in Pediatric Dilated Cardiomyopathy Are Associated with Clinical, Biochemical, and Hematological Markers of Severe Disease and Adverse Outcomes." The Journal of Heart and Lung Transplantation 43, no. 3 (2024): 379. https://doi.org/10.1016/j.healun.2023.11.014.
Citácia podľa MLA (8th ed.)Luxford, Jack C., et al. "Iron Deficiency and Anemia in Pediatric Dilated Cardiomyopathy Are Associated with Clinical, Biochemical, and Hematological Markers of Severe Disease and Adverse Outcomes." The Journal of Heart and Lung Transplantation, vol. 43, no. 3, 2024, p. 379, https://doi.org/10.1016/j.healun.2023.11.014.